Suralan® Quattro® X-Mini
Multiple Action Ecto-Endoparasitic, Low Dose, 5 Weeks of Protection
Each 500 mg chewable tablet contains:
- Sarolaner (S-Sarolaner): 5.00 mg
- Moxidectin: 0.06 mg
- Pyrantel (as embonate): 12.50 mg
- Arpraziquantel (R-Praziquantel): 6.25 mg
- Excipients and flavorings q.s. 1 tablet
Suralan® Quattro® is indicated for the treatment of dogs with, or at risk of, mixed parasitic infestations caused by endoparasites and ectoparasites, provided that simultaneous action is required against fleas, ticks, mites, nematodes (including gastrointestinal, pulmonary, ocular and heart) and cestodes (tapeworms), also preventing dirofilariosis and angiostrongylosis.
Route of Administration: Oral
Dosage:
Dog weight: 1.25 - 2.5 kg
Dosage: 1 tablet every 35 days (5 weeks)
Dosage per active ingredient:
Sarolaner: 2-4 mg/kg
Moxidectin: 0.024-0.048 mg/kg
Pyrantel: 5-10 mg/kg
Arpraziquantel: 2.5-5 mg/kg
Administration Method:
Can be administered with or without food.
Chewable and palatable tablet for easy acceptance.
If the dog does not consume it voluntarily, it can be administered with food or directly into the mouth.
Do not break or divide the tablets.
Frequency according to parasite:
Fleas and ticks: every 35 days
Sarcoptic mange: monthly for at least 2 consecutive months
Demodectic mange: monthly for at least 3 consecutive months
Heartworm/Angiostrongyliasis: monthly during the risk period
Box x 1 chewable soft tablet x 500 mg, Box x 4 chewable soft tablets x 500 mg,
SENASA Registry: F.009.031.N.00594
Petmedica® is a division of Agrovet Market S.A.
This content is an informational reference and should not be considered as
recommendation of use.
